RESULTADOS INVESTIGACIÓN

Resultados: 118

01. CYP2D6

NICARAGUA

Agúndez JA, Ramirez R, Hernandez M, Llerena A, Benítez J. Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: impact of gene-flow from Europe. Pharmacogenetics. 1997 Aug;7(4):337-40.

Llerena A, Dorado P, Ramírez R, González I, Alvarez M, Peñas-Lledó EM, Pérez B, Calzadilla LR. CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenomics J. 2012 Apr;12(2):176-83.

01. CYP2D6

01. CYP2D6

PARAGUAY

Bailliet G, Santos MR, Alfaro EL, Dipierri JE, Demarchi DA, Carnese FR, Bianchi NO. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res. 2007 Mar 5;627(2):171-7.

01. CYP2D6

PORTUGAL

Correia C, Santos P, Coutinho AM, Vicente AM. Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample. Cell Biochem Funct. 2009 Jun;27(4):251-5.

01. CYP2D6

URUGUAY

Estevez F, Giusti M, Parrillo S, Oxandabarat J. Dextromethorphan O-demethylation polymorphism in the Uruguayan population. Eur J Clin Pharmacol. 1997;52(5):417-8.

01. CYP2D6

VENEZUELA

Chiurillo MA, Grimán P,Morán Y, Camargo ME, Ramírez JL. 2009.  Analysis of CYP2D6 gene variation in Venezuelan population: Implications for forensic toxicology. Forensic Science International: Genetics SupplementSeries 2: 483–484.

Griman P, Morán Y, Carmargo M, Chiurillo MA. Characterization of cytochrome CYP2D6 allele variants in the population of the Central-Western region of Venezuela. Acta biol. Colomb. 2009; 14(1): 195-202.

Griman P, Moran Y, Valero G, Loreto M, Borjas L, Chiurillo MA. CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: pharmacogenetics and anthropological implications. Ann Hum Biol. 2012 Mar;39(2):137-42.

02. CYP2C9

ARGENTINA

Scibona P, Redal MA, Garfi LG, Arbelbide J, Argibay PF, Belloso WH. Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants. Genet Mol Res. 2012 Jan 9;11(1):70-6.

02. CYP2C9

BRASIL

Perini JA, Vargens DD, Santana IS, Moriguchi EH, Ribeiro-Dos-Santos AK, Tsutsumi M, Suarez-Kurtz G. Pharmacogenetic polymorphisms in Brazilian-born, first-generation Japanese descendants. Braz J Med Biol Res. 2009 Dec;42(12):1179-84.

Suarez-Kurtz G, Genro JP, de Moraes MO, Ojopi EB, Pena SD, Perini JA, Ribeiro-dos-Santos A, Romano-Silva MA, Santana I, Struchiner CJ. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians. Pharmacogenomics J. 2012 Jun;12(3):267-76.

Vargens DD, Petzl-Erler ML, Suarez-Kurtz G. Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. Basic Clin Pharmacol Toxicol. 2012 Apr;110(4):396-400.

Vianna-Jorge R, Perini JA, Rondinelli E, Suarez-Kurtz G. CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians. Clin Pharmacol Ther. 2004 Jul;76(1):18-26.

02. CYP2C9

BOLIVIA

Bravo-Villalta HV, Yamamoto K, Nakamura K, Bayá A, Okada Y, Horiuchi R. Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study. Eur J Clin Pharmacol. 2005 May;61(3):179-84.

02. CYP2C9

CHILE

Roco A, Quiñones L, Agúndez JA, García-Martín E, Squicciarini V, Miranda C, Garay J, Farfán N, Saavedra I, Cáceres D, Ibarra C, Varela N. Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Front Genet. 2012 Nov 2;3:229.

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies